1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Nevro Corp

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. HF10 therapy has demonstrated the ability to reduce or eliminate opioids in =65% of patients across six peer-reviewed clinical studies. The Senza® System, Senza II™ System, and the Senza® Omnia™ System are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.
D.Keith Grossman

1800 Bridge Pkwy
Redwood City, California 94065-1164
Phone: 16502510005


Wells Fargo starts coverage on Nevro stock, eyes on SCS market and growth concerns
Apr 08, 2024 09:56am


Why Nevro Stock Lagged the Market on Thursday
Feb 22, 2024 23:21pm

Despite convincing beats on its latest set of quarterly figures, the market wasn''t all that impressed with the company''s latest developments.

Source:The Motley Fool
$NVRO Nevro Corp #MWN #BreakingNews February 22, 2024 06:21:23 pm
Feb 22, 2024 23:21pm

2024-02-22 18:21:23 ET Specialty medical device maker Nevro (NYSE: NVRO) didn''t make for an inspiring investment on Thursday. Its stock price dipped marginally following the company''s release of its fourth-quarter earnings report Wednesday. That contrasted with the S&P 500 i…

Oppenheimer cuts Nevro to perform, cites weakness in core business
Feb 22, 2024 17:59pm

No summary available.

Source:Seeking Alpha
Earnings call: Nevro sees modest growth and strategic expansion in Q4
Feb 22, 2024 10:55am


Nevro Corp. (NVRO) Q4 2023 Earnings Call Transcript
Feb 22, 2024 04:02am

No summary available.

Source:Seeking Alpha
Nevro Corp (NVRO) Reports Modest Revenue Growth Amidst Strategic Shifts
Feb 21, 2024 21:43pm

Nevro Corp (NVRO) Reports Modest Revenue Growth Amidst Strategic Shifts

Nevro: Q4 Earnings Insights
Feb 21, 2024 21:30pm

Nevro (NYSE: NVRO ) reported its Q4 earnings results on Wednesday, February 21, 2024 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings Nevro beat estimated earnings by 48.98%, reporting an EPS of $-0.25 versus an … Full story available on Benzinga.com

Nevro GAAP EPS of -$0.25 beats by $0.24, revenue of $116.17M beats by $0.17M
Feb 21, 2024 21:28pm

No summary available.

Source:Seeking Alpha
Engaged Capital adds Nevro, PRA Group; exits Primo Water
Feb 14, 2024 19:48pm

No summary available.

Source:Seeking Alpha